3 UK Penny Stocks With Market Caps Under £200M

In This Article:

The United Kingdom's stock market has been under pressure recently, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic challenges. Despite these broader market concerns, penny stocks—often associated with smaller or newer companies—remain an intriguing investment area for those seeking potential growth opportunities. While the term "penny stocks" might seem outdated, these investments can still hold value when backed by strong financials and may offer unique prospects for investors aiming to uncover under-the-radar companies with long-term potential.

Top 10 Penny Stocks In The United Kingdom

Name

Share Price

Market Cap

Financial Health Rating

FRP Advisory Group (AIM:FRP)

£1.42

£348.23M

★★★★★★

ME Group International (LSE:MEGP)

£2.14

£806.26M

★★★★★★

Polar Capital Holdings (AIM:POLR)

£4.915

£473.73M

★★★★★★

Next 15 Group (AIM:NFG)

£4.29

£426.67M

★★★★☆☆

Ultimate Products (LSE:ULTP)

£1.42

£121.23M

★★★★★★

Supreme (AIM:SUP)

£1.57

£183.08M

★★★★★★

Tristel (AIM:TSTL)

£4.08

£194.41M

★★★★★★

Luceco (LSE:LUCE)

£1.398

£215.61M

★★★★★☆

Stelrad Group (LSE:SRAD)

£1.48

£188.48M

★★★★★☆

Character Group (AIM:CCT)

£2.74

£51.44M

★★★★★★

Click here to see the full list of 474 stocks from our UK Penny Stocks screener.

Let's explore several standout options from the results in the screener.

CML Microsystems

Simply Wall St Financial Health Rating: ★★★★★★

Overview: CML Microsystems plc designs, manufactures, and markets semiconductor products for the communications industries globally, with a market cap of £43.02 million.

Operations: The company generates £22.89 million in revenue from its semiconductor components tailored for the communications sector.

Market Cap: £43.02M

CML Microsystems, with a market cap of £43.02 million and revenue of £22.89 million, operates debt-free, which strengthens its financial stability. Its experienced board and management team provide strong governance. However, the company faces challenges with low return on equity at 4% and declining profit margins from 23.3% to 9%. Despite significant earnings growth over the past five years, recent negative earnings growth (-57.2%) highlights volatility in performance compared to industry averages. Recent corporate guidance indicates slightly improved operating results for early 2024, aligning with market expectations while anticipating better customer inventory levels later this year.

AIM:CML Financial Position Analysis as at Nov 2024
AIM:CML Financial Position Analysis as at Nov 2024

ECO Animal Health Group

Simply Wall St Financial Health Rating: ★★★★★★